OliX Eyes RNAi Leadership In Asia And Beyond

Emerging Company Profile: Alnylam's success with late-stage patisiran raised expectations for other RNAi firms, like South Korea's OliX Pharmaceuticals. OliX is developing locally administered treatments for dermal, ophthalmic and pulmonary indications in hopes of cementing its leadership in Asia and beyond.